AWA
RVMD icon

Aaron Wealth Advisors’s Revolution Medicines RVMD Stock Holding History

Aaron Wealth Advisors’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$500K Buy
2,670
+244
+10% +$35.6K 0.03% 420
2026
Q1 		$236K Buy
+2,426
New +$245K 0.01% 628

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Aaron Wealth Advisors's RVMD Position: Q2 2026 in Review

Aaron Wealth Advisors increased its Revolution Medicines (RVMD) stake by 10% in Q2 2026, buying an estimated $35.6K and bringing the position to 2,670 shares worth $500K. The position accounts for 0.03% of the portfolio, ranked #420.

Aaron Wealth Advisors first reported a position in RVMD in Q1 2026 and has held it in 2 quarters since. 691 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Aaron Wealth Advisors held 2,670 shares of Revolution Medicines worth $500K as of Q2 2026.
  • Aaron Wealth Advisors bought 244 Revolution Medicines shares in Q2 2026, an estimated $35.6K.
  • Revolution Medicines made up 0.03% of Aaron Wealth Advisors's portfolio in Q2 2026, its #420 holding.
  • Aaron Wealth Advisors first reported a position in Revolution Medicines in Q1 2026 and has held it in 2 quarters since.
  • 691 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Aaron Wealth Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.